Growing ribociclib-resistant tumor cells exhibited stronger communication between epithelial cells and myeloid and endothelial cells whereas ribociclib-sensitive shrinking tumors had greater communication with CD8 + T cells from both cancer and non-cancer cells (Fig. 3D top panels). This evidence concerns the gene CD8A and cancer.